PROCEPT BioRobotics Corp <PRCT.O>: UBS assumes coverage with neutral vs buy rating; target price $20 vs $30
PRCT•Related News
Coca-Cola hails World Cup hydration breaks as it lifts annual forecasts
KO•
Replimune falls after FDA staff flags efficacy concerns about skin cancer therapy
REPL•
Preview-Yum CEO faces first big test as Taco Bell outbreak clouds earnings
YUM•
Edible Garden effects 1-for-45 reverse stock split
EDBL•
Two Hands completes corporate name change to Quantum X Inc
TWOH•